NYSE - Nasdaq Real Time Price USD

Eli Lilly and Company (LLY)

733.51

+8.64

(+1.19%)

At close: April 26 at 4:00 PM EDT

733.50

-0.01

(-0.00%)

After hours: April 26 at 7:59 PM EDT

Dow Jones Futures: Nvidia Leads 7 New Buys As Market Roars; Fed, Apple, Super Micro Loom

Nvidia and several other leaders flashed buy signals as the market roared. Investors should take advantage, but it's a jungle out there.

Investor's Business Daily 11 hours ago

^GSPC

COMP

^DJI
Forget Nvidia, These Unstoppable Stocks Are Better Buys

These stocks have tremendous potential, and it doesn't depend on the growth prospects for artificial intelligence.

Motley Fool 13 hours ago

LLY
+1.19%
NVO
+0.84%
NVDA
1 Unstoppable Pharmaceutical Stock Investors Shouldn't Sleep On

Eli Lilly may be on the verge of another breakthrough, thanks to its hit GLP-1 medications.

Motley Fool 15 hours ago

LLY
+1.19%
NVO
+0.84%
Goldman Sachs’ Top 15 Stock Picks for 2024

In this article, we’ll take a look into Goldman Sachs’ top 15 stock picks for 2024. If you prefer to skip the introduction about the investment bank and its recent business developments, you can just dive straight into Goldman Sachs’ Top 5 Stock Picks for 2024. Established in 1869 by German immigrant Marcus Goldman, Goldman […]

Insider Monkey 15 hours ago

GSC

TSLA

BRK-B
3 Dividend Stocks to Buy and Hold for the Next Decade

You'll get dividends and more with these great stocks.

Motley Fool 17 hours ago

ABBV
-4.58%
PFE
+0.55%
LLY
+1.19%
How 'Megatrends' Like Weight-Loss Drugs And Smartwatches Are Bolstering ResMed

ResMed stock jumped Friday after crushing sales estimates and wiping out worries that weight-loss drugs would squeeze sleep apnea device sales.

Investor's Business Daily yesterday

RMD

LLY
+1.19%
Top 20 biopharma kick off 9.6% market cap surge in Q1 2024 amid Medicare price talks

Some companies, however, reported a market capitalisation decline, including Gilead Sciences and Roche.

Pharmaceutical Technology yesterday

LLY
+1.19%
GLDAF

ABBV
-4.58%
Is Eli Lilly Stock A Buy After Weight-Loss Drug Succeeds In Sleep Apnea Patients?

Lilly is soon planning to ask global regulators to approve tirzepatide for sleep apnea treatment. Is Eli Lilly stock a buy?

Investor's Business Daily 2 days ago

LLY
+1.19%
NVO
+0.84%
BIIB
+3.18%
20 Fastest Growing Health Tech Companies in the World

In this article, we will be taking a look at the 20 fastest growing health tech companies in the world. If you do not want to learn about the trends in digital health market, head straight to the 5 Fastest Growing Health tech Companies in the World. Explosive Growth and Key Trends in the Digital […]

Insider Monkey 2 days ago

TDOC

SNY

GSK
+0.49%
Gear Up for Lilly (LLY) Q1 Earnings: Wall Street Estimates for Key Metrics

Besides Wall Street's top -and-bottom-line estimates for Lilly (LLY), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.

Zacks 2 days ago

LLY
+1.19%
Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie

Eli Lilly, Novo Nordisk, Merck and AbbVie are part of the Zacks Industry Outlook article.

Zacks 2 days ago

NVO
+0.84%
LLY
+1.19%
ABBV
-4.58%
Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?

While the healthcare sector is expected to benefit from cutting-edge medicines, new drug approvals, technological advancements, and deal activities, it is expected to witness a modest earnings decline of 5.6% in the first quarter.

Zacks 3 days ago

PFE
+0.55%
LLY
+1.19%
AMGN
+0.22%
4 Large Drug Stocks to Hold on to Amid Industry Challenges

Drug and biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), Merck (MRK) and AbbVie (ABBV) are worth retaining in one's portfolio.

Zacks 3 days ago

ABBV
-4.58%
LLY
+1.19%
NVO
+0.84%
Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for

Pfizer (PFE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks 3 days ago

PFE
+0.55%
LLY
+1.19%
Should Eli Lilly (LLY) Be in Your Portfolio Ahead of Q1 Earnings?

Eli Lilly (LLY) enjoys strong fundamentals and is expected to consistently do well, mainly supported by its new drugs and its solid pipeline.

Zacks 3 days ago

LLY
+1.19%
Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know

Lilly (LLY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks 3 days ago

LLY
+1.19%
Meet Eli Lilly's Secret Weapon in the Billion-Dollar Weight Loss Drug Market

Lilly recently announced news that could solve a big problem.

Motley Fool 3 days ago

LLY
+1.19%
14 Dividend Growth Stocks with Highest Growth Rates

In this article, we discuss 14 dividend growth stocks with highest growth rates. You can skip our detailed analysis of dividend growth stocks and their overall performance, and go directly to read 5 Dividend Growth Stocks with Highest Growth Rates. According to a report by ProShares, the S&P 500 Dividend Aristocrats Index, which tracks the […]

Insider Monkey 3 days ago

^GSPC

GSC

LLY
+1.19%
Eli Lilly (LLY) Reports Next Week: Wall Street Expects Earnings Growth

Lilly (LLY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks 4 days ago

LLY
+1.19%
ABBV
-4.58%
Eli Lilly and Company (LLY) Rose due to Robust Q4 Sales

Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. The fund advanced 8.92% (Institutional Shares) in the quarter compared to an 8.52% gain for the Russell 3000 Health Care Index (benchmark) and a 10.56% increase for the S&P […]

Insider Monkey 4 days ago

LLY
+1.19%
^GSPC

Performance Overview

Return	LLY	S&P 500
YTD	+26.05%	+6.92%
1-Year	+92.20%	+25.26%
3-Year	+302.93%	+22.00%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Eli Lilly and Company (LLY)

Dow Jones Futures: Nvidia Leads 7 New Buys As Market Roars; Fed, Apple, Super Micro Loom

Forget Nvidia, These Unstoppable Stocks Are Better Buys

1 Unstoppable Pharmaceutical Stock Investors Shouldn't Sleep On

Goldman Sachs’ Top 15 Stock Picks for 2024

3 Dividend Stocks to Buy and Hold for the Next Decade

How 'Megatrends' Like Weight-Loss Drugs And Smartwatches Are Bolstering ResMed

Top 20 biopharma kick off 9.6% market cap surge in Q1 2024 amid Medicare price talks

Is Eli Lilly Stock A Buy After Weight-Loss Drug Succeeds In Sleep Apnea Patients?

20 Fastest Growing Health Tech Companies in the World

Gear Up for Lilly (LLY) Q1 Earnings: Wall Street Estimates for Key Metrics

Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie

Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?

4 Large Drug Stocks to Hold on to Amid Industry Challenges

Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for

Should Eli Lilly (LLY) Be in Your Portfolio Ahead of Q1 Earnings?

Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know

Meet Eli Lilly's Secret Weapon in the Billion-Dollar Weight Loss Drug Market

14 Dividend Growth Stocks with Highest Growth Rates

Eli Lilly (LLY) Reports Next Week: Wall Street Expects Earnings Growth

Eli Lilly and Company (LLY) Rose due to Robust Q4 Sales

Performance Overview